Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2019, Article ID 8495913, 10 pages
https://doi.org/10.1155/2019/8495913
Review Article

The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease

1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China
2Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China
3West China School of Medicine, Sichuan University, Chengdu, China

Correspondence should be addressed to Hu Zhang; nc.ude.ucs@uhgnahz

Received 23 August 2019; Accepted 3 October 2019; Published 3 November 2019

Academic Editor: Carla Sipert

Copyright © 2019 Chunxiang Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kaser, S. Zeissig, and R. S. Blumberg, “Inflammatory bowel disease,” Annual Review of Immunology, vol. 28, no. 1, pp. 573–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Rieder, T. Karrasch, S. Ben-Horin et al., “Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing,” Journal of Crohn's and Colitis, vol. 6, no. 3, pp. 373–385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review,” Gastroenterology, vol. 142, no. 1, pp. 46–54.e42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Marion-Letellier, G. Savoye, P. L. Beck, R. Panaccione, and S. Ghosh, “Polyunsaturated fatty acids in inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 19, no. 3, pp. 650–661, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. N. Ananthakrishnan, H. Khalili, G. G. Konijeti et al., “Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease,” Gut, vol. 63, no. 5, pp. 776–784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Uchiyama, M. Nakamura, S. Odahara et al., “N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1696–1707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Hassan, A. Ibrahim, K. Mbodji et al., “An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis,” Journal of Nutrition, vol. 140, no. 10, pp. 1714–1721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Gobbetti, J. Dalli, R. A. Colas et al., “Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection,” Proceedings of the National Academy of Sciences, vol. 114, no. 15, pp. 3963–3968, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Zhu, H. Wang, S. Wang et al., “Flaxseed oil attenuates intestinal damage and inflammation by regulating necroptosis and TLR4/NOD signaling pathways following lipopolysaccharide challenge in a piglet model,” Molecular Nutrition & Food Research, vol. 62, no. 9, 2018. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wang, F. Tian, H. Zheng et al., “N-3 polyunsaturated fatty acid-enriched lipid emulsion improves Paneth cell function via the IL-22/Stat3 pathway in a mouse model of total parenteral nutrition,” Biochemical and Biophysical Research Communications, vol. 490, no. 2, pp. 253–259, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. K. V. K. Reddy and K. A. Naidu, “Maternal and neonatal dietary intake of balanced n-6/n-3 fatty acids modulates experimental colitis in young adult rats,” European Journal of Nutrition, vol. 55, no. 5, pp. 1875–1890, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. W. M. N. Ratnayake and C. Galli, “Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper,” Annals of Nutrition & Metabolism, vol. 55, no. 1-3, pp. 8–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. A. de Silva, R. Luben, S. S. Shrestha, K. T. Khaw, and A. R. Hart, “Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries,” European Journal of Gastroenterology and Hepatology, vol. 26, no. 1, pp. 11–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Carrillo, M. Cavia Mdel, and S. Alonso-Torre, “Role of oleic acid in immune system; mechanism of action; a review,” Nutricion Hospitalaria, vol. 27, no. 4, pp. 978–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. S. Pearl, M. Masoodi, M. Eiden et al., “Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity,” Journal of Crohn's and Colitis, vol. 8, no. 1, pp. 70–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Charpentier, R. Chan, E. Salameh et al., “Dietary n-3 PUFA may attenuate experimental colitis,” Mediators of Inflammation, vol. 2018, Article ID 8430614, 10 pages, 2018. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Reifen, A. Karlinsky, A. H. Stark, Z. Berkovich, and A. Nyska, “α-Linolenic acid (ALA) is an anti-inflammatory agent in inflammatory bowel disease,” The Journal of Nutritional Biochemistry, vol. 26, no. 12, article S0955286315002004, pp. 1632–1640, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Kurashima and H. Kiyono, “Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing,” Annual Review of Immunology, vol. 35, no. 1, pp. 119–147, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Zhao, P. Shi, Y. Sun et al., “DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function,” British Journal of Nutrition, vol. 114, no. 2, pp. 181–188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Cao, C. Wang, Y. Chin et al., “DHA-phospholipids (DHA-PL) and EPA-phospholipids (EPA-PL) prevent intestinal dysfunction induced by chronic stress,” Food & Function, vol. 10, no. 1, pp. 277–288, 2019. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Beguin, A. Errachid, Y. Larondelle, and Y. J. Schneider, “Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions,” Food & Function, vol. 4, no. 6, pp. 923–931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Benoit, J. Bruno, F. Kayal et al., “Saturated and unsaturated fatty acids differently modulate colonic goblet cells in vitro and in rat pups,” Journal of Nutrition, vol. 145, no. 8, pp. 1754–1762, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Wan, Y. Fu, F. Wang, A. Sinclair, and D. Li, “Protective effects of a lipid extract from hard-shelled mussel (Mytilus coruscus) on intestinal integrity after lipopolysaccharide challenge in mice,” Nutrients, vol. 10, no. 7, p. 860, 2018. View at Publisher · View at Google Scholar · View at Scopus
  24. P. C. Calder, N. Ahluwalia, R. Albers et al., “A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies,” British Journal of Nutrition, vol. 109, Suppl 1, pp. S1–S34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Nordlander, J. Pott, and K. J. Maloy, “NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen,” Mucosal Immunology, vol. 7, no. 4, pp. 775–785, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Zhao, Z. Gong, J. Zhou et al., “Deoxycholic acid triggers NLRP3 inflammasome activation and aggravates DSS-induced colitis in mice,” Frontiers in Immunology, vol. 7, p. 536, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Scaioli, E. Liverani, and A. Belluzzi, “The imbalance between n-6/n-3 polyunsaturated fatty acids and inflammatory bowel disease: a comprehensive review and future therapeutic perspectives,” International Journal of Molecular Sciences, vol. 18, no. 12, p. 2619, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. M. T. Abreu, “Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function,” Nature Reviews Immunology, vol. 10, no. 2, pp. 131–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Ungaro, M. Fukata, D. Hsu et al., “A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis,,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 296, no. 6, pp. G1167–G1179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Luo and H. Zhang, “The role of proinflammatory pathways in the pathogenesis of colitis- associated colorectal cancer,” Mediators of Inflammation, vol. 2017, Article ID 5126048, 8 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. M. F. Neurath, “Cytokines in inflammatory bowel disease,” Nature Review Immunology, vol. 14, no. 5, pp. 329–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. D. K. McDaniel, K. Eden, V. M. Ringel, and I. C. Allen, “Emerging roles for noncanonical NF-κB signaling in the modulation of inflammatory bowel disease pathobiology,” Inflammatory Bowel Diseases, vol. 22, no. 9, pp. 2265–2279, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. K. L. Honda, S. Lamon-Fava, N. R. Matthan, D. Wu, and A. H. Lichtenstein, “Docosahexaenoic acid differentially affects TNFα and IL-6 expression in LPS- stimulated RAW 264.7 murine macrophages,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 97, pp. 27–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. E. Novak, T. A. Babcock, D. H. Jho, W. S. Helton, and N. J. Espat, “NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 284, no. 1, pp. L84–L89, 2003. View at Publisher · View at Google Scholar
  35. J. Miyamoto, T. Mizukure, S. B. Park et al., “A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway,” Journal of Biological Chemistry, vol. 290, no. 5, pp. 2902–2918, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Dubuquoy, C. Rousseaux, X. Thuru et al., “PPARγ as a new therapeutic target in inflammatory bowel diseases,” Gut, vol. 55, no. 9, pp. 1341–1349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Bassaganya-Riera, K. Reynolds, S. Martino-Catt et al., “Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease,” Gastroenterology, vol. 127, no. 3, pp. 777–791, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Marion-Letellier, P. Dechelotte, M. Iacucci, and S. Ghosh, “Dietary modulation of peroxisome proliferator-activated receptor gamma,” Gut, vol. 58, no. 4, pp. 586–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Bassaganya-Riera, M. Viladomiu, M. Pedragosa et al., “Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis,” PloS One, vol. 7, no. 2, p. e31238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Bassaganya-Riera, R. Hontecillas, W. T. Horne et al., “Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn’s disease,” Clinical Nutrition, vol. 31, no. 5, pp. 721–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Marion-Letellier, M. Butler, P. Déchelotte, R. J. Playford, and S. Ghosh, “Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation,” American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 939–948, 2008. View at Publisher · View at Google Scholar
  42. E. Kvedaraite, M. Lourda, M. Ideström et al., “Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD,” Gut, vol. 65, no. 10, pp. 1632–1641, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Gobbetti, S. Ducheix, P. le Faouder et al., “Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor,” British Journal of Pharmacology, vol. 172, no. 3, pp. 910–923, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Ibrahim, K. Mbodji, A. Hassan et al., “Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium,” Clinical Nutrition, vol. 30, no. 5, pp. 678–687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. B. Hawthorne, T. K. Daneshmend, C. J. Hawkey et al., “Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial,” Gut, vol. 33, no. 7, pp. 922–928, 1992. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Teague, B. D. Rockett, M. Harris, D. A. Brown, and S. R. Shaikh, “Dendritic cell activation, phagocytosis and CD69 expression on cognate T cells are suppressed by n-3 long-chain polyunsaturated fatty acids,” Immunology, vol. 139, no. 3, pp. 386–394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. L. H. Ly, R. Smith, K. C. Switzer, R. S. Chapkin, and D. N. McMurray, “Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 74, no. 1, pp. 29–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Tsuzuki, J. Miyazaki, K. Matsuzaki et al., “Differential modulation in the functions of intestinal dendritic cells by long- and medium-chain fatty acids,” Journal of Gastroenterology, vol. 41, no. 3, pp. 209–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Krause, M. Bruckner, C. Uermösi, E. Singer, M. Groettrup, and D. F. Legler, “Prostaglandin E (2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells,” Blood, vol. 113, no. 11, pp. 2451–2460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Arimoto-Miyamoto, N. Kadowaki, T. Kitawaki, S. Iwata, C. Morimoto, and T. Uchiyama, “Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4+ T-cell differentiation,” Immunology, vol. 130, no. 1, pp. 137–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Kanai and M. Watanabe, “Do fatty acids influence functions of intestinal dendritic cells?” Journal of Gastroenterology, vol. 41, no. 3, pp. 288-289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. B. D. Rockett, M. Salameh, K. Carraway, K. Morrison, and S. R. Shaikh, “n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo,” Journal of Lipid Research, vol. 51, no. 6, pp. 1284–1297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. B. D. Rockett, H. Teague, M. Harris et al., “Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function,” Journal of Lipid Research, vol. 53, no. 4, pp. 674–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. E. A. Gurzell, H. Teague, M. Harris, J. Clinthorne, S. R. Shaikh, and J. I. Fenton, “DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function,” Journal of Leukocyte Biology, vol. 93, no. 4, pp. 463–470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Kunisawa, E. Hashimoto, A. Inoue et al., “Regulation of intestinal IgA responses by dietary palmitic acid and its metabolism,” Journal of Immunology, vol. 193, no. 4, pp. 1666–1671, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Polese, R. Boetto, G. de Franchis et al., “B1a lymphocytes in the rectal mucosa of ulcerative colitis patients,” World Journal of Gastroenterology, vol. 18, no. 2, pp. 144–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Q. Rehman, D. Beal, Y. Liang et al., “B cells secrete eotaxin-1 in human inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 19, no. 5, pp. 922–933, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. L. A. Zenewicz, A. Antov, and R. A. Flavell, “CD4 T-cell differentiation and inflammatory bowel disease,” Trends in Molecular Medicine, vol. 15, no. 5, pp. 199–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. H. L. Woodworth, S. J. McCaskey, D. M. Duriancik et al., “Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis,” Cancer Research, vol. 70, no. 20, pp. 7960–7969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. M. Monk, T. Y. Hou, H. F. Turk et al., “Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis,” PloS One, vol. 7, no. 11, p. e49739, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Monk, Q. Jia, E. Callaway et al., “Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice,” Journal of Nutrition, vol. 142, no. 1, pp. 117–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Nagy-Szakal, S. A. V. Mir, R. A. Harris et al., “Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis,” FASEB Journal, vol. 29, no. 8, pp. 3151–3159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. J. M. Monk, H. F. Turk, Y. Y. Fan et al., “Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity,” Mediators of Inflammation, vol. 2014, Article ID 917149, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. C. H. Huang, Y. C. Hou, M. H. Pai, C. L. Yeh, and S. L. Yeh, “Dietary ω-6/ω-3 polyunsaturated fatty acid ratios affect the homeostasis of Th/Treg cells in mice with dextran sulfate sodium–induced colitis,” JPEN: Journal of Parenteral and Enteral Nutrition, vol. 41, no. 4, pp. 647–656, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. C. N. Serhan and N. A. Petasis, “Resolvins and protectins in inflammation resolution,” Chemical Reviews, vol. 111, no. 10, pp. 5922–5943, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Arita, F. Bianchini, J. Aliberti et al., “Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1,” Journal of Experimental Medicine, vol. 201, no. 5, pp. 713–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Chiang, J. Dalli, R. A. Colas, and C. N. Serhan, “Identification of resolvin D2 receptor mediating resolution of infections and organ protection,” Journal of Experimental Medicine, vol. 212, no. 8, pp. 1203–1217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. I. M. Fierro, S. P. Colgan, G. Bernasconi et al., “Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells,” Journal of Immunology, vol. 170, no. 5, pp. 2688–2694, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. R. E. E. Abdulnour, J. Dalli, J. K. Colby et al., “Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 46, pp. 16526–16531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Maeyashiki, S. Oshima, Y. Nibe, M. Kobayashi, and M. Watanabe, “Mo1303 identification of autophagic regulators as therapeutic targets in intestinal epithelial cells,” Gastroenterology, vol. 150, no. 4, pp. S692–S692, 2016. View at Publisher · View at Google Scholar
  71. C. Y. Chiu, B. Gomolka, C. Dierkes et al., “Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis,” Inflammation Research, vol. 61, no. 9, pp. 967–976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Prieto, C. E. Rosales-Mendoza, V. Terrón et al., “Activation of autophagy in macrophages by pro-resolving lipid mediators,” Autophagy, vol. 11, no. 10, pp. 1729–1744, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Godson, S. Mitchell, K. Harvey, N. A. Petasis, N. Hogg, and H. R. Brady, “Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages,” Journal of Immunology, vol. 164, no. 4, pp. 1663–1667, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. J. M. Schwab, N. Chiang, M. Arita, and C. N. Serhan, “Resolvin E1 and protectin D1 activate inflammation-resolution programmes,” Nature, vol. 447, no. 7146, pp. 869–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Krishnamoorthy, A. Recchiuti, N. Chiang et al., “Resolvin D1 binds human phagocytes with evidence for proresolving receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1660–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Ariel, G. Fredman, Y. P. Sun et al., “Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression,” Nature Immunology, vol. 7, no. 11, pp. 1209–1216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. T. Hamabata, T. Nakamura, S. Masuko, S. Maeda, and T. Murata, “Production of lipid mediators across different disease stages of dextran sodium sulfate-induced colitis in mice,” Journal of Lipid Research, vol. 59, no. 4, pp. 586–595, 2018. View at Publisher · View at Google Scholar · View at Scopus
  78. A. F. Bento, R. F. Claudino, R. C. Dutra, R. Marcon, and J. B. Calixto, “Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice,” Journal of Immunology, vol. 187, no. 4, pp. 1957–1969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Marcon, A. F. Bento, R. C. Dutra, M. A. Bicca, D. F. P. Leite, and J. B. Calixto, “Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis,” Journal of Immunology, vol. 191, no. 8, pp. 4288–4298, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. A. P. Davenport, S. P. H. Alexander, J. L. Sharman et al., “International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands,” Pharmacological Reviews, vol. 65, no. 3, pp. 967–986, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. A. J. Bilotta and Y. Cong, “Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine,” Precision Clinical Medicine, vol. 2, no. 2, pp. 110–119, 2019. View at Publisher · View at Google Scholar
  82. M. Pizzonero, S. Dupont, M. Babel et al., “Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic,” Journal of Medicinal Chemistry, vol. 57, no. 23, pp. 10044–10057, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. A. T. Suckow and C. P. Briscoe, “Key questions for translation of FFA receptors: from pharmacology to medicines,” Handbook of Experimental Pharmacology, vol. 236, pp. 101–131, 2017. View at Publisher · View at Google Scholar · View at Scopus
  84. C. F. Burant, P. Viswanathan, J. Marcinak et al., “TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial,” Lancet, vol. 379, no. 9824, pp. 1403–1411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. D. S. Im, “FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation,” Molecular Aspects of Medicine, vol. 64, pp. 92–108, 2018. View at Publisher · View at Google Scholar · View at Scopus
  86. J. M. Kim, K. P. Lee, S. J. Park et al., “Omega-3 fatty acids induce Ca2+ mobilization responses in human colon epithelial cell lines endogenously expressing FFA4,” Acta Pharmacologica Sinica, vol. 36, no. 7, pp. 813–820, 2015. View at Publisher · View at Google Scholar · View at Scopus